schizophrenia
Conditions
Interventions
A 60-minute single group psychoeducational session using the "
Guide for pharmacological therapy of Schizophrenia 2022"
Sponsors
University of Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients who are judged by their attending psychiatrist to meet the diagnostic criteria for schizophrenia according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th edition). - Persons who are judged by the attending psychiatrist to be eligible to participate in the study. - Age 18 years or older at the time consent is obtained. - Those who have given written consent to participate in the study.
Exclusion criteria
Exclusion criteria: - Persons with comorbid dementia - Persons whose psychiatric symptoms are considered to be affected by substances or other medical conditions - Other persons deemed unsuitable by the principal investigator or principal investigator-in-charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Knowledge of Medication for Schizophrenia Before and After Psychoeducation | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the level of practice of receiving treatment using the Guide and attitude toward medications before the implementation of psychoeducation and every 6 months up to 18 months thereafter. Changes in patients' Quality Of Life from before psychoeducation up to 5 years every 6 months thereafter. | — |
Countries
Japan
Contacts
Public ContactKayo Ichihashi
University of Tokyo Hospital Department of Neuropsychiatry
Outcome results
None listed